ClinicalTrials.Veeva

Menu

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

N

North Estonia Medical Centre

Status

Unknown

Conditions

Appendicitis Perforated
Acute Appendicitis Without Peritonitis
Appendicitis; Perforation
Acute Appendicitis With Rupture
Acute Appendicitis
Appendicitis Acute
Acute Appendicitis With Appendix Abscess

Treatments

Other: Oral versus intravenous administration of antibacterial treatment

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients diagnosed with acute appendicitis and are candidates for laparoscopic appendectomy.

Exclusion criteria

Patients with compromised immune system (HIV, diabetes), ongoing or completed radio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

24 hour intravenous antibacterial therapy
Active Comparator group
Description:
S.Augmentin 1,2g x 3 i/v
Treatment:
Other: Oral versus intravenous administration of antibacterial treatment
24 hour oral antibacterial therapy
Experimental group
Description:
T.Augmentin 1g x 3 p/o
Treatment:
Other: Oral versus intravenous administration of antibacterial treatment

Trial contacts and locations

1

Loading...

Central trial contact

Sten Saar, MD, PhD; Edgar Lipping, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems